Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) EBIT: 2017-2020

Historic EBIT for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$82.2 million.

  • Cogent Biosciences' EBIT fell 611.43% to -$11.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.2 million, marking a year-over-year decrease of 155.45%. This contributed to the annual value of -$82.2 million for FY2020, which is 155.45% down from last year.
  • Cogent Biosciences' EBIT amounted to -$82.2 million in FY2020, which was down 155.45% from -$32.2 million recorded in FY2019.
  • Cogent Biosciences' 5-year EBIT high stood at -$26.2 million for FY2017, and its period low was -$82.2 million during FY2020.
  • In the last 3 years, Cogent Biosciences' EBIT had a median value of -$36.0 million in 2018 and averaged -$50.1 million.
  • In the last 5 years, Cogent Biosciences' EBIT rose by 10.63% in 2019 and then plummeted by 155.45% in 2020.
  • Over the past 4 years, Cogent Biosciences' EBIT (Yearly) stood at -$26.2 million in 2017, then crashed by 37.68% to -$36.0 million in 2018, then increased by 10.63% to -$32.2 million in 2019, then plummeted by 155.45% to -$82.2 million in 2020.